These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 425079)
41. The role of factor XII in contact system activation. Hack CE Blood; 1998 Jul; 92(2):703-4. PubMed ID: 9657777 [No Abstract] [Full Text] [Related]
42. Zymogens and cofactors of blood coagulation. Nemerson Y; Furie B CRC Crit Rev Biochem; 1980; 9(1):45-85. PubMed ID: 6777115 [TBL] [Abstract][Full Text] [Related]
43. [The plasma contact system towards a different vision of blood coagulation]. Grek V; Adam A; Damas J Rev Med Liege; 1988 Oct; 43(19):623-32. PubMed ID: 3187262 [No Abstract] [Full Text] [Related]
44. Platelet-coagulant protein interactions in contact activation. Walsh PN; Griffin JH Ann N Y Acad Sci; 1981; 370():241-52. PubMed ID: 7023319 [TBL] [Abstract][Full Text] [Related]
49. Formation of the fibrin clot: the balance of procoagulant and inhibitory factors. Lämmle B; Griffin JH Clin Haematol; 1985 Jun; 14(2):281-342. PubMed ID: 2994929 [TBL] [Abstract][Full Text] [Related]
50. The binding and cleavage characteristics of human Hageman factor during contact activation. A comparison of normal plasma with plasmas deficient in factor XI, prekallikrein, or high molecular weight kininogen. Revak SD; Cochrane CG; Griffin JH J Clin Invest; 1977 Jun; 59(6):1167-75. PubMed ID: 864009 [TBL] [Abstract][Full Text] [Related]
51. Activation of factor XII and prekallikrein with polysaccharide sulfates and sulfatides: comparison with kaolin-mediated activation. Shimada T; Sugo T; Kato H; Yoshida K; Iwanaga S J Biochem; 1985 Feb; 97(2):429-39. PubMed ID: 2861197 [TBL] [Abstract][Full Text] [Related]
53. [Defects in the intrinsic pathway of the coagulation system]. Gormsen J; Clausen NT Ugeskr Laeger; 1976 May; 138(20):1204-6. PubMed ID: 1273918 [No Abstract] [Full Text] [Related]
54. Defective intrinsic fibrinolytic activity in a patient with severe factor XII-deficiency and myocardial infarction. Lodi S; Isa L; Pollini E; Bravo AF; Scalvini A Scand J Haematol; 1984 Jul; 33(1):80-2. PubMed ID: 6463588 [TBL] [Abstract][Full Text] [Related]
55. [Protein and gene structures of the contact factors and their abnormalities]. Fujikawa K; Asakai R Tanpakushitsu Kakusan Koso; 1988 Apr; 33(5):976-83. PubMed ID: 3270916 [No Abstract] [Full Text] [Related]
56. Interactions among Hageman factor (HG, Factor XII), plasma thromboplastin antecedent (PTA, Factor XI), plasma prekallikrein (PK, Fletcher factor) and high molecular weight kininogen (HMW-K, Fitzgerald factor) in blood coagulation. Saito H; Ratnoff OD Adv Exp Med Biol; 1979; 120B():61-70. PubMed ID: 517254 [TBL] [Abstract][Full Text] [Related]
57. [Role of the contact plasma system in human physiopathology]. Sánchez-Ibarrola A; Villaro J; Subirá ML Rev Esp Fisiol; 1989; 45 Suppl():233-8. PubMed ID: 2701761 [TBL] [Abstract][Full Text] [Related]
58. The role of HF cofactor in the Hageman factor-dependent fibrinolytic mechanism. Iatridis PG; Gadarowski JJ; Iatridis SG Acta Haematol; 1981; 66(4):257-63. PubMed ID: 6800192 [TBL] [Abstract][Full Text] [Related]